Aberrant TIMP-1 production in tumor-associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma

1. Duch, P.
2. Díaz-Valdivia, N.
3. Gabasa, M.
4. Ikemori, R.
5. Arshakyan, M.
6. Fernández-Nogueira, P.
7. Llorente, A.
8. Teixido, C.
9. Ramírez, J.
10. Pereda, J.
11. Chuliá-Peris, L.
12. Galbis, J.M.
13. Hilberg, F.
14. Reguart, N.
15. Radisky, D.C.
16. Alcaraz, J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1111/CAS.16141 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus